This bill bans the use of federally provided research funds by people or institutions that are carrying out federally funded research to enter into research collaborations with certain foreign entities or individuals associated with those entities. The list of restricted foreign entities is defined by references to many existing U.S. government lists (for example, the Commerce Bureau of Industry and Security Entity List, the Treasury OFAC Specially Designated Nationals list, the Department of Defense Chinese Military Companies list, the FCC Covered List, and others). The Office of Science and Technology Policy (OSTP), working with federal research agencies, must issue government-wide guidance to standardize how agencies implement the rules, definitions, and enforcement. Agency heads may grant case-by-case waivers if the waiver is needed to advance U.S. national security or is essential for a clearly defined scientific, public health, or national security purpose that cannot reasonably be achieved without the collaboration. Agencies that grant waivers must notify Congress within 30 days and include the identity of the person or entity, the justification, and any mitigation measures. The bill also defines "research collaboration" to include joint projects, co-authorship, data sharing, material transfers, joint labs or centers, personnel exchanges, and other arrangements determined by funding agencies.
If you participate in, receive, or perform work under a federally funded research award, you generally cannot use those funds to collaborate with entities or people on the U.S. restricted entity lists. Restricted activities include joint research, co-authoring papers, sharing or accessing datasets or software, transferring materials, running joint labs, and hosting visiting scholars or jointly supervising students. OSTP will issue guidance that sets out compliance rules and enforcement. Federal agencies can allow specific collaborations through waivers, but those waivers must be reported to Congress with details and any mitigation steps.
No publicly available information.
The bill is written to limit federally funded research collaborations with entities identified on U.S. restricted lists and to standardize compliance across agencies. It includes a waiver process for cases where collaboration is necessary for national security or essential scientific or public health purposes and requires reporting to Congress when waivers are granted.
No publicly available information.